London[email protected] | +44 20 3 465 1204 | v-Card
Ping Shek is a Managing Director in Stifel’s Global Healthcare Group and focuses on strategic transactions and financings for European companies. He joined Stifel in 2023 through the Torreya acquisition.Ping has expertise in cross-border transactions, having worked on deals in more than 25 jurisdictions throughout North America, Europe, Middle East, South Asia, East Asia, Australasia, and Africa. Before joining Torreya in 2017, Ping helped develop the M&A advisory business at PharmaVentures, where he worked on transactions and strategy assignments in biotech, pharma, pharma services, medical devices, life science tools, and healthcare services worldwide.
Ping was a co-founder of the integrated strategy/M&A execution practice at Monitor Group and played a pivotal role in growing the practice in London, New York and Boston. Earlier, Ping served as an Associate at Lazard in London, where he worked on public takeovers, M&A transactions, IPOs, rights issues, privatizations, and restructurings. Ping began his investment banking career as an Analyst in the M&A Department at Morgan Stanley’s London office.
Ping holds an M.A. in physics from Oxford University, as well as an M.B.A. with distinction in advanced corporate finance from London Business School.